Barry Ritholtz speaks with the people that shape markets, investing and business.
…
continue reading
IgA Nephropathy Podcasts
1
IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option
Travere Therapeutics
0
1
Listeners can expect to learn about: • The disease burden and underlying pathophysiology of IgA nephropathy, including the role of endothelin and angiotensin in disease progression • The current IgAN treatment landscape • The response to sparsentan, a dual endothelin angiotensin receptor antagonist, in patients with IgA nephropathy in the phase 3 PROTECT trial
…
continue reading
KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.
…
continue reading
A bite-size podcast brought to you by the International Society of Glomerular Disease. Nephrologists and glomerular disease experts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) take a lighthearted look at the latest research, discuss clinical practice, and interview leaders in glomerular medicine — all in a short enough time to listen on your coffee break.
…
continue reading
1
Targeting IgA Nephropathy (Sponsored Content)
18:23
18:23
Play later
Play later
Lists
Like
Liked
18:23
Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn’t know it, but he may have already saved his mom’s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy – a serious kidney di…
…
continue reading
1
Getting Earnings Right with Deutsche Bank's Binky Chadha
1:18:16
1:18:16
Play later
Play later
Lists
Like
Liked
1:18:16
Barry speaks with Binky Chadha, Chief US Equity & Global Strategist at Deutsche Bank Securities. They discuss Binky's time with the IMF and his role at Deutsche Bank as an equity strategist. They also discussed making asset allocations and market cycles. See omnystudio.com/listener for privacy information.…
…
continue reading
1
Alternate Investing: Masters in Business with Kristin Olson
51:41
51:41
Play later
Play later
Lists
Like
Liked
51:41
Barry speaks with Kristin Olson, global head of alternatives for wealth at Goldman Sachs. They discuss the alternate investing space. Kristen and Barry also discuss allocating money long-term and making alternatives more accessible to individual investors. See omnystudio.com/listener for privacy information.…
…
continue reading
1
Ceres Partners CIO Brandon Zick on How Private Equity Invests in Farmland
1:09:50
1:09:50
Play later
Play later
Lists
Like
Liked
1:09:50
Barry speaks with Brandon Zick, Chief Investment Officer at Ceres Partners. They discuss how his private equity company invests in farmland, and food, agriculture and water. They also discussed his path into finance from growing up on a farm, to studying finance and Japanese in college. See omnystudio.com/listener for privacy information.…
…
continue reading
Have you taken full advantage of automating your investments? You can improve your returns, reduce emotional decision-making, and generally end up with better results simply by putting your investing on autopilot. Jeffrey Ptak is the managing director at Morningstar. Previously, he was the chief ratings officer. Each week, “At the Money” discusses …
…
continue reading
1
What Went Wrong in Great Financial Crisis Stimulus with Reporter Jon Hilsenrath
1:32:08
1:32:08
Play later
Play later
Lists
Like
Liked
1:32:08
Barry speaks with Jon Hilsenrath, founder of Serpa Pinto Advisory. They discuss Jon's career at the Wall Street Journal as a reporter, earning him the title of "Fed Whisperer," and the response to the Great Financial Crisis. They also discussed his belief the US is undergoing the post-industrial economic revolution. See omnystudio.com/listener for …
…
continue reading
Land is more than just a place to build a house, commercial building or farm. Real assets can be monetized through Mineral and gas rights, solar and wind, recreation, even AI. Brandon Zick is Chief Investment Officer of Ceres Farmland Fund (now part of Wisdom Tree); they own and manage about $2 billion in agricultural land assets. Each week, “At th…
…
continue reading
1
Episode 28: APOL1 Screening and Early Detection - Patient and Clinician Perspectives
13:30
13:30
Play later
Play later
Lists
Like
Liked
13:30
In the final episode of KDIGO’s three-part Conversations in Nephrology series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Titilayo Ilori, MD (Boston University, United States), and kidney health advocate Joshua Albright (United States) about how APOL1 genetic testing can shape the future …
…
continue reading
1
Episode 27: Management of Patients with APOL1 Kidney Disease
19:15
19:15
Play later
Play later
Lists
Like
Liked
19:15
In this second installment of KDIGO’s three-part podcast series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), welcomes Barry Freedman, MD (Wake Forest University School of Medicine, United States) for a practical discussion on patient management. They examine how APOL1 risk variants influence progressi…
…
continue reading
1
Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease
13:00
13:00
Play later
Play later
Lists
Like
Liked
13:00
This is the first episode of a three-part KDIGO Conversations in Nephrology series on APOL1 kidney disease. Host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Bessie Young, MD (University of Washington, United States) about the discovery, burden, and biology of APOL1 kidney disease. Their discussion explores how APOL1 v…
…
continue reading
1
Market Cycles and Investment Strategy With Charles Schwab's Liz Ann Sonders
1:10:43
1:10:43
Play later
Play later
Lists
Like
Liked
1:10:43
Barry speaks with Liz Ann Sonders, chief investment strategist at Charles Schwab. Liz Ann focuses on the entire economy. She’s also the cohost of the On Investing podcast and a keynote speaker at numerous company and industry conferences. Liz Ann and Barry discuss her investment experience, working with Charles Schwab, and market cycles. See omnyst…
…
continue reading
In this Board Review Bonus episode of GN in Ten, hosts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) dive into the crucial topic of Lupus Nephritis. Special guest, Northwell fellow Dr. Mahmoud Abdelaziz, asks Kenar and Koyal the tough questions about key topics in diagnosing and managing LN. Tune in to…
…
continue reading
1
At The Money: How Big Can Active ETFS Get?
18:53
18:53
Play later
Play later
Lists
Like
Liked
18:53
ETFs gained a reputation for providing investors with low-cost index exposure, but many of the newest funds are actively managed. Some are costly and speculative. What is an ETF investor to do? Dave Nadig is President and Director of Research at ETF.com, and he shares with us how investors should navigate all of these new products. He helped design…
…
continue reading
Make sense of the world with one essential conversation, every week. Mishal Husain, one of Britain's best interviewers, brings her signature blend of curiosity and tenacity to weekly conversations with world leaders, business titans, and cultural icons, revealing who they really are and how they see the world changing around them. Follow the podcas…
…
continue reading
1
Carta CEO Henry Ward on Private Credit & Private Markets
57:02
57:02
Play later
Play later
Lists
Like
Liked
57:02
Barry speaks with Henry Ward, Chief Executive Officer at Carta, a technology company that provides capitalization table management and valuation software for startups. They discuss founding a business, the growth of private markets, and his lobby efforts for retail investors to access private markets. See omnystudio.com/listener for privacy informa…
…
continue reading
1
At The Money: Don’t Underperform Your Own Investments!
14:29
14:29
Play later
Play later
Lists
Like
Liked
14:29
Are you underperforming our own investments? Did you know that many, maybe even most, investors do worse than the ETFs and Mutual Funds they hold do? The annual Morningstar study “Mind the Gap” has found a substantial difference between returns generated by investment funds and the actual returns investors experience. Jeffrey Ptak is the managing d…
…
continue reading
1
'Barbell' Investing Strategies With Jurrien Timmer
1:28:51
1:28:51
Play later
Play later
Lists
Like
Liked
1:28:51
Barry Ritholtz speaks with Jurrien Timmer, director of global macro at Fidelity investments. They discuss his career path, key market charts and Timmer's "barbell approach" to investing in both high-flying tech stocks and equities outside of the US. See omnystudio.com/listener for privacy information.…
…
continue reading
Farmland is a real asset that can be accessed through private funds. The asset has seen broad, non-correlated gains, hedged against rising prices. And farming acreage shrinks every year. Brandon Zick is Chief Investment Officer of Ceres Farmland Fund (now part of Wisdom Tree); the fund owns and manages about $2 billion in agricultural land assets. …
…
continue reading
1
BNY's Jose Minaya on How AI Is Transforming Asset Management
56:33
56:33
Play later
Play later
Lists
Like
Liked
56:33
Barry speaks with Jose Minaya, global head of BNY Investments and Wealth. In this episode, Jose and Barry discuss his career buy-side trading, investing in the alternatives space. The also discuss the changes blockchain and AI are bringing to asset management. See omnystudio.com/listener for privacy information.…
…
continue reading
1
Episode 25: Treatment Revolution in Iga Nephropathy
14:30
14:30
Play later
Play later
Lists
Like
Liked
14:30
Join Dana Rizk, MD (University of Alabama at Birmingham, USA), and Shikha Wadhwani, MD (Indiana University School of Medicine, USA), for a conversation on the treatment revolution in IgAN. They discuss how breakthroughs in understanding disease pathophysiology are fueling a wave of new therapies that go beyond traditional supportive care. Key topic…
…
continue reading
